|
IQVIA™ Real-World Insights Bibliography
| The emerging role of real-world data in advanced breast cancer therapy: Recommendations for collaborative decision-making
|
| Author(s): Paul Cottu 1, Scott David Ramsey 2, Oriol Solà-Morales 3, Patricia A Spears 4, Lockwood Taylor 5 |
| Affiliations(s): 1Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm, 75005, Paris, France. Electronic address: paul.cottu@curie.fr.
2Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M2-B232, Seattle, WA, 98155, USA. Electronic address: sramsey@fredhutch.org.
3Health Innovation Technology Transfer Foundation, Aragó 60, E-08015, Barcelona, Spain. Electronic address: osola@fhitt.org.
48605 Carolingian Court, Raleigh, NC, 27615, USA. Electronic address: paspears88@gmail.com.
5Epidemiology, Real World Solutions at IQVIA, 4820 Emperor Boulevard, Durham, NC, 27703, USA. Electronic address: lockwood.taylor@iqvia.com. |
Publication(s): Breast. 2021 Dec 22;61:118-122. doi: 10.1016/j.breast.2021.12.015.
|
| Document Type(s): Article, |
| Countries: France, Italy, USA, |
| Click here for the abstract |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment, Drug safety, Oncology, Regulatory,
2022 |
|
L:
A: |
English
Review, |
|
 |
| |
| |
| Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 |
| Author(s): Janet Sultana 1 2, Salvatore Crisafulli 3, Mariana Almas 4, Ippazio Cosimo Antonazzo 5 6, Esme Baan 7, Claudia Bartolini 6, Maria Paola Bertuccio 3, Fedele Bonifazi 8 9, Annalisa Capuano 10 11, Antonella Didio 8 9, Vera Ehrenstein 12, Mariagrazia Felisi 8 13, Carmen Ferrajolo 10 11, Andrea Fontana 14, Remy Francisca 7, Annie Fourrier-Reglat 15, Joan Fortuny 16, Rosa Gini 6, Giulia Hyeraci 6, Christel Hoeve 7, Christos Kontogiorgis 17, Valentina Isgrò 18, Panagiotis-Nikolaos Lalagkas 17, Luca L'Abbate 18, Deborah Layton 19, Annalisa Landi 8 9, Silvia Narduzzi 19, Leonardo Roque Pereira 20, Georgios Poulentzas 17, Concetta Rafaniello 10 11, Giuseppe Roberto 6, Giulia Scondotto 3, Liberata Sportiello 10 11, Maddalena Toma 8 9, Massoud Toussi 19, Katia Verhamme 7, Elisabetta Volpe 8 9, Gianluca Trifirò 18, |
| Affiliations(s): Pharmacy Department, Mater Dei Hospital, Msida, Malta.
2Exeter College of Medicine and Health, Exeter, UK.
3Department of Medicine, University of Verona, Verona, Italy.
4Real World Solutions Department, IQVIA, Lisbon, Portugal.
5Research Centre on Public Health (CESP), University of Milan-Bicocca, Milan, Italy.
6Agenzia Regionale di Sanità della Toscana, Florence, Italy.
7Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, The Netherlands.
8TEDDY European Network of Excellence for Paediatric Clinical Research, Pavia, Italy.
9Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Bari, Italy.
10Department of Experimental Medicine, University of Campania "Vanvitelli", Naples, Italy.
11Campania Regional Center of Pharmacovigilance and Pharmacoepidemiology, Naples, Italy.
12Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
13CVBF Consorzio per Valutazioni Biologiche e Farmacologiche, Pavia, Italy.
14Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
15Univ. Bordeaux, INSERM, Bordeaux Population Health Research Center, Team of Pharmacoepidemiology, UMR 1219, Bordeaux, France.
16RTI Health Solutions, Barcelona, Spain.
17Democritus University of Thrace, Alexandroupolis, Greece.
18Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
19Data Science Hub, Real World Solutions, IQVIA, London, UK.
20Department of Datascience & Biostatistics, University Medical Center Utrecht, Utrecht, The Netherlands. |
Publication(s): Pharmacoepidemiol Drug Saf
. 2022 Jun;31(6):689-705. doi: 10.1002/pds.5413. Epub 2022 Feb 11.
|
| Document Type(s): Article, |
| Countries: Denmark, France, Italy, Netherlands, Portugal, Spain, UK, |
| Click here for the abstract |
C:
Y: |
Drug safety, Drug Utlization Study,
2022 |
|
L:
A: |
English
Database Study, Review, |
|
|
| |
| |
| Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy |
| Author(s): Colombo GL, Heiman F, Peduto I |
| Affiliations(s): Colombo GL: CEFAT - Department of Drug Sciences, University of Pavia, Pavia, Italy. Peduto I, Heiman F: IQVIA Solutions Italy S.r.l., Milan, Italy, |
Publication(s): Ther Clin Risk Manag. 2021 Apr 21;17:345-356. doi: 10.2147/TCRM.S301005
|
| Document Type(s): Article, |
| Countries: Italy, |
| Click here for the abstract |
C:
Y: |
Health economics, Overactive bladder,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, Cost of illness, |
|
|
| |
| |
| Impact of lurasidone and other antipsychotics on body weight: real-world, retrospective, comparative study of 15,323 adults with schizophrenia
|
| Author(s): Pochiero I, Calisti F, Comandini A, Del Vecchio A, Costamagna I, Rosignoli MT, Cattaneo A, Nunna S, Peduto I, Heiman F, Chang H, Chen C, Correll C
|
| Affiliations(s): Pochiero I: Angelini Regulatory, Research & Development, Angelini Pharma S.p.A., Rome, Italy; Peduto I and Heiman F: IQVIA Solutions Italy Srl, RWS
|
Publication(s): Int J Gen Med. 2021 Jul 31;14:4081-4094. doi: 10.2147/IJGM.S320611. PMID: 34366678; PMCID: PMC8336993.
|
| Document Type(s): Article, |
| Countries: Italy, USA, |
| Click here for the abstract |
C:
Y: |
Mental health, Metabolic Disorders ,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, Epidemiological study, Retrospective database analysis, |
|
|
| |
| |
| Analisi di impatto sul budget sanitario italiano di gilteritinib per il trattamento della leucemia mieloide acuta FLT3+ recidivante o refrattaria
|
| Author(s): Fiorentino F, La Malfa P, Di Rienzo P
|
| Affiliations(s): Fiorentino F: IQVIA Solutions Italy Srl, RWS
|
Publication(s): GIHTAD (2021) 14:4
|
| Document Type(s): Article, |
| Countries: Italy, |
| Click here for the abstract |
C:
Y: |
Health economics, Oncology,
2021 |
|
L:
A: |
Italian
Budget impact, clinical setting: Secondary care, |
|
|
| |
| |
| First Italian guidelines for the economic evaluation of health technologies: how do they compare to NICE standards?
|
| Author(s): Fiorentino F, Urbinati D
|
| Affiliations(s): Fiorentino F: IQVIA Solutions Italy Srl, RWS
|
Publication(s): GIHTAD (2021) 14:5
|
| Document Type(s): Letter, |
| Countries: Italy, |
| Click here for the abstract |
C:
Y: |
Health policy,
2021 |
|
L:
A: |
English
Public Health, |
|
|
| |
| |
| Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy
|
| Author(s): Mennini FS, Gori M, Vlachaki I, Fiorentino F, La Malfa P, Urbinati D, Andreoni M
|
| Affiliations(s): Mennini FS: EEHTA CEIS, Faculty of Economics, University of Rome "Tor Vergata", Rome, Italy; Fiorentino F, La Malfa P, Urbinati D: IQVIA Solutions Italy Srl, RWS
|
Publication(s): Health Econ Rev. 2021 Oct 30;11(1):42. doi: 10.1186/s13561-021-00341-z. PMID: 34716794; PMCID: PMC8557067.
|
| Document Type(s): Article, |
| Countries: Italy, |
| Click here for the abstract |
C:
Y: |
Respiratory disease,
2021 |
|
L:
A: |
English
clinical setting: Secondary care, Cost effectiveness, |
|
|
| |
| |
| An Italian individual-level data study investigating on the association between air pollution exposure and Covid-19 severity in primary-care setting
|
| Author(s): Pegoraro V, Heiman F, Levante A, Urbinati D, Peduto I |
| Affiliations(s): Pegoraro V, Heiman F, Levante A, Urbinati D, Peduto I: IQVIA Solutions Italy S.r.l., Milan, Italy,
|
Publication(s): BMC Public Health. 2021 May 12;21(1):902. doi: 10.1186/s12889-021-10949-9
|
| Document Type(s): Article, |
| Countries: Italy, |
| Click here for the abstract |
C:
Y: |
Infectious disease, Public Health,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, Epidemiological study, Public Health, |
|
|
| |
| |
| The Burden of Short-Acting β 2-Agonist Use in Asthma: Is There an Italian Case? An Update from SABINA Program
|
| Author(s): Di Marco F, D'Amato M, Lombardo FP, Micheletto C, Heiman F, Pegoraro V, Boarino S, Manna F, Mastromauro F, Spennato S, Papi A
|
| Affiliations(s): Di Marco F: Department of Health Sciences, University of Milan, Respiratory Unit, ASST Papa Giovanni XXIII, Bergamo, Italy. Pegoraro V, Heiman F: IQVIA Solutions Italy S.r.l., Milan, Italy,
|
Publication(s): Adv Ther. 2021 May 27. doi: 10.1007/s12325-021-01772-0
|
| Document Type(s): Article, |
| Countries: Italy, |
| Click here for the abstract |
C:
Y: |
Respiratory disease,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis, |
|
|
| |
| |
| Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy
|
| Author(s): Colombo GL, Heiman F, Peduto I
|
| Affiliations(s): Colombo GL: CEFAT - Department of Drug Sciences, University of Pavia, Pavia, Italy. Peduto I, Heiman F: IQVIA Solutions Italy S.r.l., Milan, Italy,
|
Publication(s): Ther Clin Risk Manag. 2021 Apr 21;17:345-356. doi: 10.2147/TCRM.S301005
|
| Document Type(s): Article, |
| Countries: Italy, |
| Click here for the abstract |
C:
Y: |
Health economics, Orthopedics,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, Cost of illness, Retrospective database analysis, |
|
|
| |
| |
 1 of 30 
|
|
